<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274818/" ref="ordinalpos=4501&amp;ncbi_uid=3793869&amp;link_uid=PMC3274818" image-link="/pmc/articles/PMC3274818/figure/F1/" class="imagepopup">Fig. 1.  From: Evolving Therapies and FAK Inhibitors for the Treatment of Cancer. </a></div><br /><div class="p4l_captionBody">Activation of an RTK induces dimerization and downstream phosphorylation of non-receptor tyrosine kinases. Major signaling cascades include the RAS/RAF/MAPK pathway, MEK pathway, and the PI3kinase/AKT pathway.(Adapted by permission from Macmillan Publishers Ltd: Nature Reviews Cancer, Zhu &amp; Parada, Nature Reviews Cancer, 2002, 2: 616â€“626, copyright 2002.)</div></div>